Wolverine Trading’s Enzo Biochem, Inc. ENZ Stock Holding History

Wolverine Trading’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,266	Closed	-$31.6K	–	5104
2022 Q4	$30K	Buy	+21,266	New	+$41.4K	﹤0.01%	3684
2021 Q4	–	Sell	-28,842	Closed	-$102K	–	7053
2021 Q3	$102K	Buy	28,842 +8,759	+44%	+$29.2K	﹤0.01%	5758
2021 Q2	$62K	Sell	20,083 -32,597	-62%	-$103K	﹤0.01%	5559
2021 Q1	$173K	Buy	52,680 +19,653	+60%	+$61.1K	﹤0.01%	5158
2020 Q4	$86K	Buy	33,027 +18,216	+123%	+$39.7K	﹤0.01%	4505
2020 Q3	$31K	Buy	14,811 +674	+5%	+$1.6K	﹤0.01%	4346
2020 Q2	$32K	Buy	+14,137	New	+$36.3K	﹤0.01%	4381
2018 Q4	–	Sell	-10,223	Closed	-$42K	–	5512
2018 Q3	$42K	Buy	+10,223	New	+$46.4K	﹤0.01%	4733
2017 Q4	–	Sell	-11,288	Closed	-$118K	–	5619
2017 Q3	$118K	Buy	+11,288	New	+$125K	﹤0.01%	4019

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's ENZ Position: Q1 2023 in Review

Wolverine Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 21,266 shares — an estimated $31.6K sold.

Wolverine Trading first reported a position in ENZ in Q3 2017 and held it in 9 quarters. The position peaked at $173K in Q1 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

Wolverine Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
Wolverine Trading sold 21,266 Enzo Biochem, Inc. shares in Q1 2023, an estimated $31.6K.
Wolverine Trading first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 9 quarters.
Wolverine Trading's Enzo Biochem, Inc. position peaked at $173K in Q1 2021.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Wolverine Trading's 13F filing for Q1 2023, filed 15 May 2023.